enGene Holdings is trading 5.74% higher at $1.67 after-hours, with no clear company-specific catalyst identified.
- It closed at $1.58 on October 19; its press-release archive lists an October 13 release as its latest entry.
- The broad market finished higher: the Nasdaq Composite rose 1.94% and the S&P 500 gained 0.56%. This may have supported the move, but a direct link is unconfirmed.
- Recent analyst commentary and trial discussion predate October 19 and do not establish a fresh catalyst.